Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109).

Hirt D, Urien S, Ekouévi D, Rey E, Arrivé E, Blanche S, Amani-Bosse C, Nerrienet E, Gray G, Kone M, Leang S, McIntyre J, Dabis F, Tréluyer JM.

Clin Pharmacol Ther. 2008 Nov 5. [Epub ahead of print]

PMID: 18987623 [PubMed - as supplied by publisher]

Related Articles

Gateways to clinical trials.

Tomillero A, Moral MA.

Methods Find Exp Clin Pharmacol. 2008 Sep;30(7):543-88.

PMID: 18985183 [PubMed - in process]

Related Articles

Pharmacologic aspects of new antiretroviral drugs.

Long MC, King JR, Acosta EP.

Curr Infect Dis Rep. 2008 Nov;10(6):522-9.

PMID: 18945395 [PubMed - in process]

Related Articles

Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry.

Nirogi R, Bhyrapuneni G, Kandikere V, Mudigonda K, Komarneni P, Aleti R, Mukkanti K.

Biomed Chromatogr. 2008 Oct 20. [Epub ahead of print]

PMID: 18937306 [PubMed - as supplied by publisher]

Related Articles

Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India.

Pujari S, Dravid A, Gupte N, Joshi K, Bele V.

Medscape J Med. 2008;10(8):196. Epub 2008 Aug 20.

PMID: 18924648 [PubMed - in process]

Related Articles Free article in PMC

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.

Mira JA, López-Cortés LF, Barreiro P, Tural C, Torres-Tortosa M, de Los Santos Gil I, Martín-Rico P, Ríos-Villegas MJ, Hernández-Burruezo JJ, Merino D, López-Ruz MA, Rivero A, Muñoz L, González-Serrano M, Collado A, Macías J, Viciana P, Soriano V, Pineda JA.

J Antimicrob Chemother. 2008 Dec;62(6):1365-73. Epub 2008 Oct 13.

PMID: 18854330 [PubMed - in process]

Related Articles

Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada(R)) in virologically suppressed HIV-infected patients on HAART.

Palacios R, Hidalgo C, Ríos MJ, Rivero A, Muñoz L, Lozano F, Gutiérrez-Ravé V, Gálvez MC, Del Arco A, Santos J.

Eur J Clin Microbiol Infect Dis. 2008 Oct 8. [Epub ahead of print]

PMID: 18841401 [PubMed - as supplied by publisher]

Related Articles

Pathogenesis and treatment of lipodystrophy: what clinicians need to know.

Sattler FR.

Top HIV Med. 2008 Oct-Nov;16(4):127-33. Review.

PMID: 18838747 [PubMed - indexed for MEDLINE]

Related Articles

The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients.

Gallant JE, Winston JA, DeJesus E, Pozniak AL, Chen SS, Cheng AK, Enejosa JV.

AIDS. 2008 Oct 18;22(16):2155-63.

PMID: 18832879 [PubMed - in process]

Related Articles

Bayesian network analyses of resistance pathways against efavirenz and nevirapine.

Deforche K, Camacho RJ, Grossman Z, Soares MA, Van Laethem K, Katzenstein DA, Harrigan PR, Kantor R, Shafer R, Vandamme AM; non-B Workgroup.

AIDS. 2008 Oct 18;22(16):2107-15.

PMID: 18832874 [PubMed - in process]

Related Articles

Atriplatrade mark - HIV therapy in one pill.

Julg B, Bogner JR.

Ther Clin Risk Manag. 2008 Jun;4(3):573-7.

PMID: 18827852 [PubMed - in process]

Related Articles Free article in PMC

Management of patients with decompensated hepatitis B virus association cirrhosis.

Zoulim F, Radenne S, Ducerf C.

Liver Transpl. 2008 Oct;14 Suppl 2:S1-7.

PMID: 18825719 [PubMed - in process]

Related Articles

The prevalence of hepatitis B co-infection in a South African urban government HIV clinic.

Firnhaber C, Reyneke A, Schulze D, Malope B, Maskew M, MacPhail P, Sanne I, Di Bisceglie A.

S Afr Med J. 2008 Jul;98(7):541-4.

PMID: 18785395 [PubMed - indexed for MEDLINE]

Related Articles

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

Schackman BR, Scott CA, Walensky RP, Losina E, Freedberg KA, Sax PE.

AIDS. 2008 Oct 1;22(15):2025-33.

PMID: 18784465 [PubMed - in process]

Related Articles

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study.

Gomes NA, Vaidya VV, Pudage A, Joshi SS, Parekh SA.

J Pharm Biomed Anal. 2008 Nov 4;48(3):918-26. Epub 2008 Aug 5.

PMID: 18783908 [PubMed - in process]

Related Articles

Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.

Redfield RR, Morrow JS.

Clin Infect Dis. 2008 Oct 1;47(7):984-5. No abstract available.

PMID: 18778234 [PubMed - in process]

Related Articles

CD4 count improvement following tenofovir to abacavir switch in a patient with persistent lymphopenia despite an undetectable viral load.

Condoluci DV, Andrews M, Luber AD.

AIDS Read. 2008 Aug;18(8):410-2.

PMID: 18770899 [PubMed - indexed for MEDLINE]

Related Articles

Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course.

Prada N, Davis B, Jean-Pierre P, La Roche M, Duh FM, Carrington M, Poles M, Mehandru S, Mohri H, Markowitz M.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):117-22.

PMID: 18769360 [PubMed - indexed for MEDLINE]

Related Articles

"White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients.

Podsadecki TJ, Vrijens BC, Tousset EP, Rode RA, Hanna GJ.

HIV Clin Trials. 2008 Jul-Aug;9(4):238-46.

PMID: 18753118 [PubMed - indexed for MEDLINE]

Related Articles

Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily.

Elion R, Cohen C, Ward D, Ruane P, Ortiz R, Reddy YS, Ebrahimi R, McColl D, Kearney B, Fisher A, Flaherty J; BATON Study Group.

HIV Clin Trials. 2008 Jul-Aug;9(4):213-24.

PMID: 18753116 [PubMed - indexed for MEDLINE]

Related Articles